DIZAL (JIANGSU) PHARMACEUTICAL revenue breakdown overview

DIZAL (JIANGSU) PHARMACEUTICAL revenue for the last year amounted to 91.00 M CNY, the most of which — 91.29 M CNY — came from its highest performing source at the moment, Innovative Drugs, the year earlier bringing 10.29 M CNY. The greatest contribution to the revenue figure was made by China — last year it brought DIZAL (JIANGSU) PHARMACEUTICAL 91.29 M CNY, and the year before that — 10.29 M CNY.